Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with a need for better tools to guide treatment selection and follow‐up. The aim of this prospective study was to investigate the prognostic value and treatment monitoring potential of longitudinal circulating tumour DNA (ctDNA) measurement...

全面介紹

書目詳細資料

發表在:	Molecular Oncology
Main Authors:	Karin Hestnes Edland, Kjersti Tjensvoll, Satu Oltedal, Ingvild Dalen, Morten Lapin, Herish Garresori, Nils Glenjen, Bjørnar Gilje, Oddmund Nordgård
格式:	Article
語言:	英语
出版:	Wiley 2023-09-01
主題:	circulating tumour DNA ctDNA disease/treatment monitoring KRAS pancreatic cancer pancreatic ductal adenocarcinoma
在線閱讀:	https://doi.org/10.1002/1878-0261.13472